Breaking News Instant updates and real-time market news.

TRVN

Trevena

$6.03

0.11 (1.86%)

14:20
10/19/16
10/19
14:20
10/19/16
14:20

Meet Trevena: CEO Gowen says product development on track

In an exclusive interview with The Fly, Trevena's (TRVN) CEO Maxine Gowen commented on the progress of two other product candidates being developed by the company, aside from its lead drug Oliceridine: "TRV250 is our investigational product with a potential first in class mechanism for the treatment of episodic migraine. Migraine is a condition for which the currently available treatments are really insufficient for millions of patients. We hope to submit an IND to the FDA later this year, and that should enable us to start clinical trials next year. So that's on track. '734, which is our investigational product for oral treatment of moderate to severe acute pain has completed its Phase 1 trials. While it's related to Oliceridine, it does have a different chemical structure and we will be looking to reach different clinical endpoints because this is now for acute and chronic pain taken orally, and the unmet needs for chronic pain are rather different from those for acute hospital pain. Because commercialization of '734 for chronic pain really isn't an ideal fit for our stated hospital and specialist focus, we think that it does make sense to evaluate partnering opportunities now. So that is still our plan." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company. The remainder of this interview to follow.

  • 22

    Oct

  • 13

    Dec

TRVN Trevena
$6.03

0.11 (1.86%)

03/02/16
WBTH
03/02/16
INITIATION
Target $18
WBTH
Buy
Trevena initiated with a Buy at WallachBeth
WallachBeth analyst Caroline Palomeque started Trevena with a Buy rating and $18 price target. The company's lead candidate Oliceridine for post-operative acute pain may offer patients a treatment option with comparable analgesic efficacy, a faster onset of action and a more favorable safety profile than morphine, Palomeque tells investors in a research note.
03/02/16
03/02/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chemical Financial (CHFC) initiated with a Strong Buy at Raymond James by analyst David Long, who believes its pending accretive merger with Talmer Bancorp (TLMR) will provide the base for a more profitable company with strengthened growth prospects. 2. Infinity Pharmaceuticals (INFI) initiated with an Outperform at FBR Capital, with analyst Christopher James saying that duvelisib has the potential to be a first-in-class treatment for specific types of blood cancers. 3. Trevena (TRVN) initiated with a Buy at WallachBeth by analyst Caroline Palomeque, who said Oliceridine may offer patients a treatment option with comparable analgesic efficiency, a faster onset of action and a more favorable safety profile than morphine. 4. Aduro Biotech (ADRO) initiated with an Outperform at FBR Capital. 5. LKQ Corp. (LKQ) initiated with a Buy at Sterne Agee CRT. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/29/16
FBRC
03/29/16
INITIATION
Target $16
FBRC
Outperform
Trevena initiated with an Outperform at FBR Capital
FBR Capital analyst Christopher James started Trevena with an Outperform rating and $16 price target.
05/17/16
ROTH
05/17/16
NO CHANGE
Target $14.5
ROTH
Buy
Roth Capital remains a buyer of Trevena
Roth Capital analyst Michael Higgins reiterates a Buy rating and $14.50 price target on Trevena's shares. The analyst says the company announced that its TRV027 failed in Phase 2 and will be discontinuing the program. However, given the relative risk of development between its oliceridine and its TRV027, Higgins is not making any changes to his financial models. Trevena is "well-capitalized," with cash sufficient to fund operations for two years, the analyst tells investors in a research note, adding that he sees the company's shares as being at an "attractive entry point."

TODAY'S FREE FLY STORIES

NEM

Newmont Mining

$33.73

-0.08 (-0.24%)

09:55
06/26/17
06/26
09:55
06/26/17
09:55
Options
Newmont Mining put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MU

Micron

$31.73

-0.16 (-0.50%)

, AAP

Advance Auto Parts

$121.72

1.98 (1.65%)

09:55
06/26/17
06/26
09:55
06/26/17
09:55
Options
Early notable gainers among liquid option names on June 26th »

Notable gainers among…

MU

Micron

$31.73

-0.16 (-0.50%)

AAP

Advance Auto Parts

$121.72

1.98 (1.65%)

AIZ

Assurant

$102.87

1.62 (1.60%)

OKE

Oneok

$49.80

0.61 (1.24%)

KIM

Kimco Realty

$18.21

0.22 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 27

    Jul

  • 29

    Aug

09:55
06/26/17
06/26
09:55
06/26/17
09:55
General news
FX Action: USD-CAD »

FX Action: USD-CAD faded…

ALNY

Alnylam

$85.21

1.25 (1.49%)

09:53
06/26/17
06/26
09:53
06/26/17
09:53
Recommendations
Alnylam analyst commentary  »

Alnylam data support…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 06

    Jul

TPX

Tempur Sealy

$50.14

0.28 (0.56%)

09:52
06/26/17
06/26
09:52
06/26/17
09:52
Recommendations
Tempur Sealy analyst commentary  »

Tempur Sealy added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICON

Iconix Brand

$6.62

0.12 (1.85%)

09:50
06/26/17
06/26
09:50
06/26/17
09:50
Conference/Events
Iconix Brand management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SVA

Sinovac Biotech

$5.70

-0.02 (-0.35%)

09:50
06/26/17
06/26
09:50
06/26/17
09:50
Hot Stocks
Breaking Hot Stocks news story on Sinovac Biotech »

Sinovac Biotech trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CECE

CECO Environmental

$9.34

0.09 (0.97%)

09:48
06/26/17
06/26
09:48
06/26/17
09:48
Conference/Events
CECO Environmental management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

PRTS

U.S. Auto Parts

$3.23

0.01 (0.31%)

09:47
06/26/17
06/26
09:47
06/26/17
09:47
Conference/Events
U.S. Auto Parts management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SGEN

Seattle Genetics

$61.74

-1.51 (-2.39%)

09:46
06/26/17
06/26
09:46
06/26/17
09:46
Recommendations
Seattle Genetics analyst commentary  »

Piper says Seattle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MLM

Martin Marietta

09:44
06/26/17
06/26
09:44
06/26/17
09:44
Technical Analysis
Technical View: Martin Marietta up after Bluegrass Materials acquisition »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

F

Ford

09:42
06/26/17
06/26
09:42
06/26/17
09:42
Conference/Events
Ford to host sales conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 26

    Jul

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

, MTSI

MACOM

$58.26

1.76 (3.12%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Recommendations
Applied Optoelectronics, MACOM, Fabrinet, Amazon.com analyst commentary  »

Needham says Applied…

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

MTSI

MACOM

$58.26

1.76 (3.12%)

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

AAPL

Apple

$146.28

0.65 (0.45%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Technical Analysis
Technical View: Apple rises, levels to watch »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LOW

Lowe's

, VRX

Valeant

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Options
Unusually active option classes on open June 26th »

Unusual total active…

LOW

Lowe's

VRX

Valeant

CSCO

Cisco

$32.09

0.24 (0.75%)

BIDU

Baidu

$178.14

-1.19 (-0.66%)

P

Pandora

NKE

Nike

TWTR

Twitter

COST

Costco

$157.13

-2.66 (-1.66%)

GLD

SPDR Gold Trust

AAPL

Apple

$146.28

0.65 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 19

    Jul

  • 16

    Aug

  • 23

    Aug

  • 24

    Aug

09:40
06/26/17
06/26
09:40
06/26/17
09:40
General news
Vehicle Inventories Pose Risk For Auto Retooling »

Vehicle Inventories Pose…

ARNC

Arconic

09:38
06/26/17
06/26
09:38
06/26/17
09:38
Technical Analysis
Technical View: Arconic trades sharply lower »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCAP

Triangle Capital

09:37
06/26/17
06/26
09:37
06/26/17
09:37
Upgrade
Triangle Capital rating change  »

Triangle Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Upgrade
FirstEnergy rating change  »

FirstEnergy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Recommendations
Fabrinet, Amazon.com, Tesla analyst commentary  »

Fabrinet price target…

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

TSLA

Tesla

$383.45

0.84 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

  • 02

    Oct

SGEN

Seattle Genetics

$61.74

-1.51 (-2.39%)

09:31
06/26/17
06/26
09:31
06/26/17
09:31
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MDXG

MiMedx

$15.71

0.14 (0.90%)

09:30
06/26/17
06/26
09:30
06/26/17
09:30
Recommendations
MiMedx analyst commentary  »

MiMedx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

, COST

Costco

$157.13

-2.66 (-1.66%)

09:28
06/26/17
06/26
09:28
06/26/17
09:28
Conference/Events
Cowen internet and retail analysts hold an analyst/industry conference call »

Internet & New Media…

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

COST

Costco

$157.13

-2.66 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 23

    Aug

CGIX

Cancer Genetics

$3.85

0.05 (1.32%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Initiation
Cancer Genetics initiated  »

Cancer Genetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.14

-0.16 (-12.31%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Hot Stocks
Trovagene reports receipt of notice of event of default from lender »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.